Back

Inhibiting chondroitin sulfate synthase 1 ameliorates hyperplastic arterial remodelling

31 August 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Novel mechanisms of atherosclerosis Vascular Diseases: Fibrosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Doctor Dan Liao

National University of Singapore, Singapore (Singapore)

Photo
Mr Wei Seng Chng

(Singapore)

7 More presentations in this session

Presentation thumbnail
A novel VCP modulator, KUS121, attenuates atherosclerosis progression by maintaining intracellular ATP and mitigating ER stress in endothelial cells
Doctor O. Baba (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease
Doctor V. Nankivell (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis
Doctor M. Drozd (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Profiling the L-arginine/arginase 1 metabolism in early and advanced atherosclerosis
Mrs Y. Wu (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Myeloid Tgfbr1/2-deficiency leads to a pro-atherogenic environment in ApoE-/- mice
Doctor V. Bazioti (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Novel mechanisms of atherosclerosis

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET
You may be interested in
thumbnail
Congress Session
Novel insights into vascular remodelling
thumbnail
Congress Session
Young Investigator Awards Session in Basic Science
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources